Quantitative detection of serum adenovirus in a transplant recipient [2]

Lancet

Volumn 359, Issue 9321, 2002, Pages 1945-

  Teramura, Tomoko ^a   Naya, Mayumi ^b   Yoshihara, Takao ^b   Morimoto, Akira ^b   Imashuku, Shinsaku ^b  

^a Kyoto City Institute of Health and Environmental Sciences   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MELPHALAN; METHOTREXATE; PREDNISOLONE; RIBAVIRIN; VIDARABINE;

ACUTE MYELOBLASTIC LEUKEMIA; BLOOD ANALYSIS; BONE MARROW; BONE MARROW TRANSPLANTATION; CASE REPORT; EPSTEIN BARR VIRUS; FEMALE; FEVER; GENOME ANALYSIS; GRAFT REJECTION; HEMATURIA; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LETTER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHOOL CHILD; TRANSPLANTATION; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION;

EID: 0036606507     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08749-4     Document Type: Letter

References (5)

1. Prediction of severe disseminated adenovirus infection by serum PCR
2. Adenovirus infections in patients undergoing bone marrow transplantation
3. Adenoviruses in the immunocompromised host
4. Real time quantitative PCR
5. Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients